A review of candidate therapies for Middle East respiratory syndrome from a molecular perspective
Review
[키워드] acute respiratory syndrome
Antibiotics
antiviral peptide
camostat
cathepsin L
clinical trials
Combination
Controlled clinical trial
convalescent
convalescent plasma
Corticosteroids
current therapy
DPP4
East
effective
furin protease
GLS-5300
glycopeptide antibiotic
high mortality rate
host proteases
include
inhibitor
interferon
interferons
laboratory-confirmed
Lopinavir
Lopinavir–ritonavir
M(pro)
Medline database
MERS-CoV
Middle East
molecular
monoclonal antibodies
mortality rate
Mutation
pandemic
Perspective
PL(pro)
potential therapy
protease
required
respiratory syndrome coronavirus
ribavirin
S protein
SARS-CoV
searched
subject
syndrome
Therapies
therapy
TMPRSS2
Transmissibility
urgency
Vaccine
vaccine candidates
Variation
viral S protein
[DOI] 10.1099/jmm.0.000565 PMC 바로가기 [Article Type] Review
[DOI] 10.1099/jmm.0.000565 PMC 바로가기 [Article Type] Review